当前位置: X-MOL 学术eLife › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis
eLife ( IF 7.7 ) Pub Date : 2020-07-07 , DOI: 10.7554/elife.58227
Tyler Wagner 1 , Fnu Shweta 2 , Karthik Murugadoss 1 , Samir Awasthi 1 , A J Venkatakrishnan 1 , Sairam Bade 3 , Arjun Puranik 1 , Martin Kang 1 , Brian W Pickering 2 , John C O'Horo 2 , Philippe R Bauer 2 , Raymund R Razonable 2 , Paschalis Vergidis 2 , Zelalem Temesgen 2 , Stacey Rizza 2 , Maryam Mahmood 2 , Walter R Wilson 2 , Douglas Challener 2 , Praveen Anand 3 , Matt Liebers 1 , Zainab Doctor 1 , Eli Silvert 1 , Hugo Solomon 1 , Akash Anand 3 , Rakesh Barve 3 , Gregory Gores 2 , Amy W Williams 2 , William G Morice 2, 4 , John Halamka 2 , Andrew Badley 2 , Venky Soundararajan 1
Affiliation  

Understanding temporal dynamics of COVID-19 symptoms could provide fine-grained resolution to guide clinical decision-making. Here, we use deep neural networks over an institution-wide platform for the augmented curation of clinical notes from 77,167 patients subjected to COVID-19 PCR testing. By contrasting Electronic Health Record (EHR)-derived symptoms of COVID-19-positive (COVIDpos; n = 2,317) versus COVID-19-negative (COVIDneg; n = 74,850) patients for the week preceding the PCR testing date, we identify anosmia/dysgeusia (27.1-fold), fever/chills (2.6-fold), respiratory difficulty (2.2-fold), cough (2.2-fold), myalgia/arthralgia (2-fold), and diarrhea (1.4-fold) as significantly amplified in COVIDpos over COVIDneg patients. The combination of cough and fever/chills has 4.2-fold amplification in COVIDpos patients during the week prior to PCR testing, in addition to anosmia/dysgeusia, constitutes the earliest EHR-derived signature of COVID-19. This study introduces an Augmented Intelligence platform for the real-time synthesis of institutional biomedical knowledge. The platform holds tremendous potential for scaling up curation throughput, thus enabling EHR-powered early disease diagnosis.

中文翻译:

来自大型 EHR 系统的临床记录的增强管理揭示了即将诊断出 COVID-19 的症状

了解 COVID-19 症状的时间动态可以提供细粒度的分辨率来指导临床决策。在这里,我们在机构范围的平台上使用深度神经网络来增强对 77,167 名接受 COVID-19 PCR 测试的患者的临床记录的管理。通过对比 PCR 测试日期前一周的 COVID-19 阳性(COVIDpos;n = 2,317)与 COVID-19 阴性(COVIDneg;n = 74,850)患者的电子健康记录 (EHR) 衍生症状,我们确定了嗅觉缺失/味觉障碍(27.1倍)、发烧/寒战(2.6倍)、呼吸困难(2.2倍)、咳嗽(2.2倍)、肌痛/关节痛(2倍)和腹泻(1.4倍)同样显着在 COVIDpos 中对 COVIDneg 患者进行了放大。咳嗽和发烧/发冷的组合有 4。除了嗅觉障碍/味觉障碍外,在 PCR 测试前一周内 COVIDpos 患者的 2 倍扩增构成了 COVID-19 最早的 EHR 衍生特征。本研究引入了一个增强智能平台,用于实时合成机构生物医学知识。该平台具有扩大治疗吞吐量的巨大潜力,从而实现 EHR 支持的早期疾病诊断。
更新日期:2020-07-07
down
wechat
bug